alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
(a)
    
    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure the material information relating to the
Registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this report is being prepared;(b)
    
    Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted
accounting principles;(c)
    
    Evaluated the effectiveness of the Registrants disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and(d)
    
    Disclosed in this report any change in the Registrants internal
control over financial reporting that occurred during the Registrants
most recent fiscal quarter (the Registrants fourth fiscal quarter in
the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the Registrants internal
control over financial reporting; and
  (a)
    
    All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the Registrants ability to
record, process summarize and report financial information; and(b)
    
    Any fraud, whether or not material, that involves management or other
employees who have a significant role in the Registrants internal
controls over financial reporting.
  By:
    /s/ James W. Creamer, IIIJames W. Creamer, IIIPresident & CEO
Online!Online!Online!                Online!              

        - Contents            - Welcome
          - Introduction
          - Phenomena (incl. eclipses)
          - Time-Scales and Coordinate Systems
          - Sun
          - Moon
          - Planets
          - Natural Satellites
          - Dwarf Planets and Small Solar System Bodies
          - Stars and Stellar Systems
          - Observatory Search
          - Tables and Data
          - Notes and References
          - Glossary 
        - Errata            - Errata 2018
          - Errata 2017
          - Errata 2016
          - Errata 2015
          - Errata 2014
          - Errata 2013
          - Errata 2012
          - Errata 2011
          - Errata 2010
          - Errata 2009
          - Errata 2008
          - Errata 2007
          - Errata 2006
          - Errata 2005
          - Errata 2004
          - Errata 2003
          - Errata 2002
          - Errata 2001 
        - Constants
        - Glossary
        - Utilities            - Planetary Geocentric Coordinates 
        - Additional Info            - Additional Resources
          - Noted Links
          - Contributors
          - Ordering
          - Legal
          - Contact Us 

Geocentric coordinates for 0h TT on

			The Diary of Phenomena for the entire year is presented below in iCalendar format. To use, right-click the link below and save it to your computer. You will then be able to import it into any program that understands the iCalendar 2.0 format, such as iCal, Outlook, Google Calender, etc.		
asao_diary17.icsasao_diary18.ics

# Welcome

*The Astronomical Almanac* is a joint publication of the U.S.    Nautical Almanac Office, United States Naval Observatory (USNO), in the    United States and Her Majesty's Nautical Almanac Office (HMNAO), United    Kingdom Hydrographic Office (UKHO), in the United Kingdom. The printed    version contains precise ephemerides of the Sun, Moon, planets, and    satellites, data for eclipses and other astronomical phenomena for a given    year, and serves as a world-wide standard for such information. The online    version extends the printed version by providing data best presented in    machine-readable form.  

    These pages are available at USNO    and HMNAO (WEB700).  

 

          -  Introduction   
          -  Errata in printed editions   
          -  Section A: Phenomena (incl. eclipses)   
          -  Section B: Time-Scales and Coordinate Systems   
          -  Section C: Sun   
          -  Section D: Moon   
          -  Section E: Planets   
          -  Section F: Natural Satellites   
          -  Section G: Dwarf Planets and Small Solar System Bodies   
          -  Section H: Stars and Stellar Systems   
          -  Section J: Observatory Search   
          -  Section K: Tables and Data   
          -  Section L: Notes and References   
          -  Section M: Glossary   
          -  Section N: Index   
          -  Additional Information   

Diary of Phenomena

The Astronomical Almanac Online! 2020
Part 5336 - Construction and Architect-Engineer Contracts       DAFFARS PART 5336 Knowledge Center          *Revised: June 2023*                                       Subpart 5336.2 – SPECIAL ASPECTS OF CONTRACTING FOR CONSTRUCTION                                                         5336.208 Concurrent Performance of Firm-Fixed-Price and Other Types of Construction Contracts                                                            5336.209 Construction Contracts with Architect-Engineer Firms                                                            5336.213-2 Presolicitation Notices                                                            5336.270 Expediting construction contracts                                                            5336.272 Prequalification of Sources                                                                             Subpart 5336.3 – TWO-PHASE DESIGN-BUILD SELECTION PROCEDURES                                                         5336.301 Use of Two-Phase Design-Build Selection Procedures                                                            5336.303-1 Phase One                                                                             Subpart 5336.5 – CONTRACT CLAUSES                                                         5336.507 Permits and Responsibilities                                                            5336.570 Additional Provisions and Clauses                                                                             Subpart 5336.6 – ARCHITECT-ENGINEER SERVICES                                                         5336.602-3 Evaluation Board Functions                                                            5336.609-1 Design Within Funding Limitations    Subpart 5336.2 – SPECIAL ASPECTS OF CONTRACTING FOR CONSTRUCTION                                   5336.208 Concurrent Performance of Firm-Fixed-Price and Other Types of Construction Contracts       See MP5301.601(a)(i).5336.209 Construction Contracts with Architect-Engineer Firms       See MP5301.601(a)(i). Submit a copy of the approval to SAF/AQCA Workflow.5336.213-2 Presolicitation Notices       (a) See MP5301.601(a)(i).5336.270 Expediting construction contracts       (a) See MP5301.601(a)(i).5336.272 Prequalification of Sources       (b) See MP5301.601(a)(i).Subpart 5336.3 – TWO-PHASE DESIGN-BUILD SELECTION PROCEDURES                    5336.301 Use of Two-Phase Design-Build Selection Procedures       (b)(3)(vi) See MP5301.601(a)(i).5336.303-1 Phase One       (a)(4)(i)(B) See MP5301.601(a)(i).Subpart 5336.5 – CONTRACT CLAUSES                    5336.507 Permits and Responsibilities       When the clause at FAR 52.236-7, *Permits and Responsibilities*, is used in solicitations and contracts OCONUS, the clause must be modified to reflect “host government and political subdivisions” in lieu of “Federal, State, and Municipal.”5336.570 Additional Provisions and Clauses       (b)(2) See MP5301.601(a)(i).Subpart 5336.6 – ARCHITECT-ENGINEER SERVICES                    5336.602-3 Evaluation Board Functions       See MP5301.601(a)(i).5336.609-1 Design Within Funding Limitations       (c)(1) See MP5301.601(a)(i).
No: 16-033 June 6, 2016

Contact: Scott Burnell, 301-415-8200

NRC Completes Safety Review of Proposed New Reactors at Levy Site in Florida

The Nuclear Regulatory Commission staff has completed its Final Safety Evaluation Report for 

Combined Licenses (COLs) for two proposed reactors at the Levy County site in Florida. The report

concludes there are no safety aspects that would preclude issuing the license for construction and 

operation of the proposed reactors at the site.

The staff will provide the report and Final Environmental Impact Statement on the Levy County

application to the Commission for the mandatory hearing phase of the licensing process. In the 

mandatory hearing, expected to take place later this year, the Commission will examine whether the 

staff’s review supports the findings necessary to issue a license. Following the mandatory hearing, the 

Commission will vote on whether to authorize the staff to issue the license.

Progress Energy Florida (now Duke Energy Florida) submitted its COL application for Levy 

County on July 30, 2008, for permission to build and operate two AP1000 nuclear reactors at the site. 

The NRC certified the amended 1,100-megawatt AP1000 design in 2012. More information on the 

certification process is available on the NRC website.

The NRC’s Advisory Committee on Reactor Safeguards independently reviewed those aspects 

of the Levy County application that concern safety. The committee provided the results of its review to 

the Commission on Dec. 7, 2011, and provided the results of its review of several exemption requests 

on April 18, 2016. The NRC completed its environmental review and issued the final impact statement 

for the proposed Levy County reactors in April 2012.
§ 210.3A-03 Statement as to principles of consolidation or combination followed. ( a ) [Reserved]
( b ) As to each consolidated financial statement and as to each combined financial statement, if there has been a change in the persons included or excluded in the corresponding statement for the preceding fiscal period filed with the Commission that has a material effect on the financial statements, the persons included and the persons excluded shall be disclosed.
[37 FR 14597, July 21, 1972. Redesignated at 45 FR 63687, Sept. 25, 1980, and 46 FR 56179, Nov. 16, 1981; 83 FR 50200, Oct. 4, 2018]
§ 1028.115 IRB Records. ( a ) An institution, or when appropriate an IRB, shall prepare and maintain adequate documentation of IRB activities, including the following: ( 1 ) Copies of all research proposals reviewed, scientific evaluations, if any, that accompany the proposals, approved sample consent forms, progress reports submitted by investigators, and reports of injuries to subjects.
( 2 ) Minutes of IRB meetings, which shall be in sufficient detail to show attendance at the meetings; actions taken by the IRB; the vote on these actions including the number of members voting for, against, and abstaining; the basis for requiring changes in or disapproving research; and a written summary of the discussion of controverted issues and their resolution.
( 3 ) Records of continuing review activities, including the rationale for conducting continuing review of research that otherwise would not require continuing review as described in § 1028.109(f)(1).
( 4 ) Copies of all correspondence between the IRB and the investigators.
( 5 ) A list of IRB members in the same detail as described in § 1028.108(a)(2).
( 6 ) Written procedures for the IRB in the same detail as described in § 1028.108(a)(3) and (4).
( 7 ) Statements of significant new findings provided to subjects, as required by § 1028.116(c)(5).
( 8 ) The rationale for an expedited reviewer's determination under § 1028.110(b)(1)(i) that research appearing on the expedited review list described in § 1028.110(a) is more than minimal risk.
( 9 ) Documentation specifying the responsibilities that an institution and an organization operating an IRB each will undertake to ensure compliance with the requirements of this policy, as described in § 1028.103(e).
( b ) The records required by this policy shall be retained for at least 3 years, and records relating to research that is conducted shall be retained for at least 3 years after completion of the research. The institution or IRB may maintain the records in printed form, or electronically. All records shall be accessible for inspection and copying by authorized representatives of the Federal department or agency at reasonable times and in a reasonable manner.
### SUBCHAPTER IV—BIOECONOMY RESEARCH AND DEVELOPMENT
### §14044d. Transferred

#### **Editorial Notes**

#### Codification

Section 14044d was editorially reclassified as section 20706 of Title 34, Crime Control and Law Enforcement.
##### 



Exhibit 10.1
 SEPARATION AGREEMENT ANDWAIVER AND GENERAL RELEASE OF CLAIMS




---



##### 



- 2 -




---



##### 



- 3 -




---



##### 



- 4 -




---



##### 



Non-Competition
 Non-Solicitation
 Non-Disparagement
  - 5 -




---



##### 



- 6 -




---



##### 



- 7 -




---



##### 



NATIONSHEALTH, INC.
    
    
    
    TRACY M. SCHMIDTBy:
    
    /s/ Robert Tremain
    
    
    
    By:
    
    /s/ Tracy M. SchmidtTitle:
    
    Chief Operating Officer
    
    
    
    Date:
    
    06/30/06Date:
    
    06/30/06
  - 8 -




---



##### 



Exhibit 10.1
   Job duties from January 1, 2005  April 2006
  (i)
    
    reviewing operational reports
prepared by the finance department to evaluate the
performance of the operations, e.g. sales numbers,
reorder calls, cancellation rates, etc.(ii)
    
    meeting with members of the
management team including the VP of Regulatory Affairs,
VP Pharmacy Services, VP Marketing, and VP
Distribution.(iii)
    
    coordinating operations
meetings among members of operations management.(iv)
    
    identifying opportunities for
system improvements in the operations.(v)
    
    discussing operating results
with the COO, CFO, and/or CEO.
  A - 1
§ 162.9 Renewal of opt out. ( a ) *Renewal notice and opt-out requirement* — ( 1 ) *In general.* Since the FCRA provides that opt-out elections can expire in a period of no less than five years, an affiliate that has or previously had a pre-existing business relationship with a consumer must provide a renewal notice to the consumer after such time in order to allow its affiliates to make solicitations. After the opt-out election period expires, its affiliates may make solicitations unless: ( i ) The consumer has been given a renewal notice that complies with the requirements of this section and §§ 162.6 through 162.8 of this subpart, and a reasonable opportunity and a reasonable and simple method to renew the opt-out election, and the consumer does not renew the opt out; or
( ii ) An exception in Sec. 162.3(c) of this subpart applies.
( 2 ) *Renewal period.* Each opt-out renewal must be effective for a period of at least five years as provided in § 162.4(b) of this subpart.
( 3 ) *Affiliates who may provide the renewal notice.* The notice required by this paragraph must be provided: ( i ) By the affiliate that provided the previous opt-out notice, or its successor; or
( ii ) As part of a joint renewal notice from two or more members of an affiliated group of companies, or their successors, that jointly provided the previous opt-out notice.
( b ) *Contents of renewal or extension notice.* The contents of the renewal notice must include all of the same contents of the initial notices, but also must include: ( 1 ) A statement that the consumer previously elected to limit the use of certain information to make solicitations to the consumer;
( 2 ) A statement that the consumer may elect to renew the consumer's previous election; and
( 3 ) If applicable, a statement that the consumer's election to renew will apply for a specified period of time stated in the notice and that the consumer will be allowed to renew the election once that period expires.
( c ) *Timing of renewal notice.* Renewal notices must be provided in a reasonable period of time before the expiration of the opt-out election period or any time after the expiration of the opt-out period, but before solicitations that would have been prohibited by the expired opt-out election are made to the consumer.
( d ) *No effect on opt-out period.* An opt-out period may not be shortened by sending a renewal notice to the consumer before the expiration of the opt-out period, even if the consumer does not renew the opt-out election.
#### § 155.10 Exemptions.

Except as otherwise provided in this part, the Commission may, in its discretion and upon such terms and conditions as it deems appropriate, exempt any contract market or other person from any of the provisions of this part.

(Approved by the Office of Management and Budget under control numbers 3038-0007 and 3038-0022)

[41 FR 56142, Dec. 23, 1976, as amended at 46 FR 63036, Dec. 30, 1981]
#### George Terranova and Others, Copartners, etc., Respondents, v. Albert A. Volk Co., Inc., Appellant.

Order modified as directed in order, and as modified affirmed, with ten dollars costs and disbursements to appellant. No opinion. Present—Clarke, P. J., Scott, Smith, Page and Davis, JJ.
**EXHIBIT 31.1****CERTIFICATION OF CHAIRMAN AND CHIEF EXECUTIVE OFFICER**I, Vincent F. Sollitto Jr., certify that:1. I have reviewed this quarterly report on Form 10-Q of Syntax-Brillian Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations, and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and we have: a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, is made known to us by otherswithin those entities, particularly during the period in which this report is beingprepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and  c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s most recentfiscal quarter (the registrant’s fourth fiscal quarter in the case of an annualreport) that has materially affected, or is reasonably likely to materially affect,the registrant’s internal control over financial reporting.5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunction): a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likelyto adversely affect the registrant’s ability to record, process, summarize andreport financial information; and b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.Date: February 21, 2006       /s/ Vincent F. Sollitto Jr. Vincent F. Sollitto Jr.    Chairman and Chief Executive Officer
#### The People of the State of New York, Respondent, v. Michael J. Regan, Appellant.

Defendant appeals from a judgment of the County Court, Kings County, convicting him of criminal contempt of court, and from “ each and every intermediary order therein made.” It was defendant’s contention upon the trial that a waiver of immunity executed by him, prior to his appearance before the Grand Jury, while he was a New York City police officer, was ineffective, as he had not understood the full nature and scope of his act and the District Attorney had failed to advise him with respect to his rights. The question of whether defendant signed the waiver knowingly and fully aware of its import and consequences, was submitted to the jury as a question of fact. Judgment unanimously affirmed. Assuming, without deciding, that the District Attorney was under a duty to advise defendant of the nature and effect of the waiver of immunity and his rights with respect thereto, we are of the opinion that the proof established, beyond a reasonable doubt, that defendant had been *776so advised and had voluntarily and knowingly executed the waiver. Defendant’s other contentions have been examined and are without merit. The minutes of the preliminary hearings, printed in the record, have not been considered in reaching this determination. No separate appeal lies from the intermediate orders, which have been reviewed on the appeal from the judgment of conviction. (Code Grim. Pro., § 517.) Present — Nolan, P. J., Adel, Mac Crate, Schmidt and Beldoek, JJ.
#### § 150.6 Scope.

This part shall only be construed as having an effect on speculative position limits set by the Commission or by a designated contract market or swap execution facility, including any associated recordkeeping and reporting regulations in this chapter. Nothing in this part shall be construed to relieve any designated contract market, swap execution facility, or its governing board from responsibility under section 5(d)(4) of the Act to prevent manipulation and corners. Further, nothing in this part shall be construed to affect any other provisions of the Act or Commission regulations, including, but not limited to, those relating to actual or attempted manipulation, corners, squeezes, fraudulent or deceptive conduct, or to prohibited transactions.

[86 FR 3472, Jan. 14, 2021]
#### § 460.8 R-value tolerances.

If you are a manufacturer of home insulation, no individual specimen of the insulation you sell can have an R-value more than 10% below the R-value shown in a label, fact sheet, ad, or other promotional material for that insulation. If you are not a manufacturer, you can rely on the R-value data given to you by the manufacturer, unless you know or should know that the data is false or not based on the proper tests.

[70 FR 31275, May 31, 2005]